I-Afatinib CAS 439081-18-2 Ubunyulu > 99.5% (HPLC) Factory
I-Ruifu Chemical Supply Intermediates ye-Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)i-acetaldehyde I-Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
I-Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4 (1H)-enye CAS 162012-69-3
I-7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineI-CAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineI-CAS 314771-88-5
Igama leMchiza | Afatinib |
Izithethantonye | BIBW2992;BIBW-2992;BIBW2992 Isiseko sasimahla;Tomtovok;(S,E)-N-(4-(3-Chloro-4-Fluorophenylamino)-7-(Tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(Dimethylamino)kodwa-2-Enamide |
Inombolo yeCAS | 439081-18-2 |
Inombolo yeCAT | RF-PI2033 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C24H25ClFN5O3 |
Ubunzima beMolekyuli | 485.94 |
Ukunyibilika | Inyibilika kwi-DMSO |
Ukuxinana | 1.380 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | I-Off-White Powder |
Ukuchongwa | I-HPLC, NMR |
Ubunyulu / Indlela yokuHlalutya | >99.5% (HPLC) |
Indawo yokunyibilika | 100.0 ~ 102.0℃ |
Ilahleko ekomisweni | <0.50% |
Intsalela kwi-Ignition | <0.20% |
Ukungcola ngokupheleleyo | <0.50% |
Iintsimbi ezinzima | ≤20ppm |
NMR Spectrum | Iyahambelana neSakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Beka ubomi kwishelufa | Iinyanga ezingama-24 ukuba zigcinwe ngokufanelekileyo |
Ukusetyenziswa | API;Afatinib;Afatinib Dimaleate;NSCLC |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Afatinib, eyaziwa ngokuba yi-BIW-2992, (i-CAS: 439081-18-2) isizukulwana sesibini esinamandla kunye nesingenakuguqulwa inhibitor ye-epidermal growth factor receptor (EGFR) kunye ne-epidermal growth factor receptor 2 (HER2) i-tyrosine kinase, iphuhliswe nguBoehringer Ingelheim, eJamani.Iyakwazi ukuvimbela ngokungenakuguqulwa umsebenzi we-tyrosine kinase ngokufumana impendulo kaMichael kunye neqela le-thiol le-cysteine kwindawo ye-797 ye-EGFR.Ngomhla we-12 kaJulayi, i-2013, yaba lichiza elitsha lokulwa nomhlaza wemiphunga yeseli encinci evunywe yi-US FDA phantsi kwegama lezorhwebo likaGilotrif.Eli chiza yi-tablet.Isetyenziselwa unyango lwezigulana ezifunyanwe zinomhlaza wemiphunga we-metastatic ongeyonxalenye encinci yeseli (NSCLC) kunye nokulahleka kwe-19th exon okanye i-L858R utshintsho kwi-21th exon ye-tumor epidermal growth factor receptor (EGFR) eqinisekisiweyo kusetyenziswa ikiti evunyiweyo. yi-FDA.Ichiza likwasebenza kunyango lwezigulane ezine-HER2 ezinomhlaza webele ophezulu.I-Afatinib yeyeklasi yamachiza eyaziwa ngokuba yi-tyrosine kinase inhibitors.I-Tyrosine kinase inhibitors yenzelwe ukuvimba isenzo se-enzyme ethile ebizwa ngokuba yi-tyrosine kinase.Le enzyme idlala indima enkulu kumsebenzi weeseli, kwaye iyasebenza ekukhuthazeni ukukhula kwethumba kunye nokuqhubela phambili.I-Afatinib isebenza ukuvimbela umsebenzi weentlobo ezimbini ze-tyrosine kinases: i-epidermal growth factor receptor (EGFR) kunye ne-Her2, "echazwe ngokugqithiseleyo" ngeentlobo ezininzi zomhlaza.Ngokuthintela ukusebenza kwezi tyrosine kinases, i-Afatinib inokuthintela iiseli zomhlaza ekwahluleleni nasekukhuleni.